Uganda Bans Zambian Aids Drug

6 April 1997

The Uganda National Drug Authority has put on alert drug inspectors atentry points and intensified surveillance of a controversial AIDS drug, herirontinasiferon, imported from Zambia.

"The Authority has never been contacted nor authorized the importation of such a drug," Deus Mubangisis, the NDA's acting executive secretary, told the New Vision newspaper.

A consignment of the drug worth $1 million was imported late last month into Uganda, a report from Zambia's capital Lusaka said. Zambian professor Mulenga Lukwesa, the drug's inventor, claimed that his patients found the drug effective. However, the Zambian Health Ministry has banned the use and sale of the drug until competent international medical institutions have assessed it.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight